Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Czech Republic caps fuel prices amid Iran war energy crisis- Christmas 2025 skywatching guide: What you can see in the night sky on Dec. 25
- Dramatic Dominance d: A Survey of \Feelings in front of an audience\ Theater Play
- Major Scottish gangland figure Steven Lyons arrested in Bali
- Flu surges across U.S. as doctor visits reach highest level since 1997
- Vote In favor of Your Number one Game Control center
- Israel reports first missile fire from Yemen since start of Iran war
- Instructions to Clean and Really focus on Your Lab Precious stone
- East Germany Somehow Built a Real Sports Car and It Was Wild
